Načítá se...
Fetal fibronectin testing for reducing the risk of preterm birth
BACKGROUND: Fetal fibronectin (FFN) is an extracellular matrix glycoprotein localized at the maternal‐fetal interface of the amniotic membranes, between chorion and decidua, where it is concentrated in this area between decidua and trophoblast. In normal conditions, FFN is found at very low levels i...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492504/ https://ncbi.nlm.nih.gov/pubmed/18843732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006843.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|